il 17 pathway inhibitors Search Results


human anti-il-17 receptor a monoclonal antibody  (LEO Pharma)
90
LEO Pharma human anti-il-17 receptor a monoclonal antibody
Overview of the major biologic approaches currently in development for type 2 low asthma management
Human Anti Il 17 Receptor A Monoclonal Antibody, supplied by LEO Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human anti-il-17 receptor a monoclonal antibody/product/LEO Pharma
Average 90 stars, based on 1 article reviews
human anti-il-17 receptor a monoclonal antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
il-17 inhibitor secukinumab  (Institute for Clinical Pharmacodynamics)
90
Institute for Clinical Pharmacodynamics il-17 inhibitor secukinumab
Overview of the major biologic approaches currently in development for type 2 low asthma management
Il 17 Inhibitor Secukinumab, supplied by Institute for Clinical Pharmacodynamics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il-17 inhibitor secukinumab/product/Institute for Clinical Pharmacodynamics
Average 90 stars, based on 1 article reviews
il-17 inhibitor secukinumab - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
il-17 inhibitors  (Optum Inc)
90
Optum Inc il-17 inhibitors
Overview of the major biologic approaches currently in development for type 2 low asthma management
Il 17 Inhibitors, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il-17 inhibitors/product/Optum Inc
Average 90 stars, based on 1 article reviews
il-17 inhibitors - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
il-17 ra inhibitor ixekizumab  (GlpBio Technology Inc)
90
GlpBio Technology Inc il-17 ra inhibitor ixekizumab
Overview of the major biologic approaches currently in development for type 2 low asthma management
Il 17 Ra Inhibitor Ixekizumab, supplied by GlpBio Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il-17 ra inhibitor ixekizumab/product/GlpBio Technology Inc
Average 90 stars, based on 1 article reviews
il-17 ra inhibitor ixekizumab - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
il-17 inhibitors  (Firstline Biopharmaceuticals Corporation)
90
Firstline Biopharmaceuticals Corporation il-17 inhibitors
Overview of the major biologic approaches currently in development for type 2 low asthma management
Il 17 Inhibitors, supplied by Firstline Biopharmaceuticals Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il-17 inhibitors/product/Firstline Biopharmaceuticals Corporation
Average 90 stars, based on 1 article reviews
il-17 inhibitors - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
interleukin(il)-17-blocker  (Anwendung GmbH)
90
Anwendung GmbH interleukin(il)-17-blocker
Overview of the major biologic approaches currently in development for type 2 low asthma management
Interleukin(Il) 17 Blocker, supplied by Anwendung GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/interleukin(il)-17-blocker/product/Anwendung GmbH
Average 90 stars, based on 1 article reviews
interleukin(il)-17-blocker - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Overview of the major biologic approaches currently in development for type 2 low asthma management

Journal: ERJ Open Research

Article Title: Identification and treatment of T2-low asthma in the era of biologics

doi: 10.1183/23120541.00309-2020

Figure Lengend Snippet: Overview of the major biologic approaches currently in development for type 2 low asthma management

Article Snippet: Add-on therapy in uncontrolled moderate-to-severe asthma , IL-17 , Brodalumab , Human anti-IL-17 receptor A monoclonal antibody , Leo Pharma , Did not improve ACQ score, lung function or asthma symptoms , [84].

Techniques: Control